New Share Issue | IDL Biotech
IDL Biotech

CLOSE MENU

Articles

Latest News

September 2018

New Share Issue

The board of directors of IDL Biotech AB (publ) has resolved to make a new share issue of approximately SEK 39,4 million before issue costs.

Read the press release here 

Nomination Committe for IDL appointed

IDL Biotechs extra ordinary general meeting held on the 25th October 2018 decided to establish a nomination committee.

German study recommends UBC® Rapid to be added in the diagnostics and follow-up of high risk bladder cancer

International Journal of Molecular Sciences has published a study on UBC® Rapid. In total 530 urine samples was included in the multicenterstudy.

IDL Biotech

Skip this intro